ROLE OF CCK IN REGULATION OF PANCREATICOBILIARY FUNCTIONS AND GI-MOTILITY IN HUMANS - EFFECTS OF LOXIGLUMIDE

被引:101
作者
SCHMIDT, WE
CREUTZFELDT, W
SCHLESER, A
CHOUDHURY, AR
NUSTEDE, R
HOCKER, M
NITSCHE, R
SOSTMANN, H
ROVATI, LC
FOLSCH, UR
机构
[1] UNIV GOTTINGEN,DEPT GEN SURG,W-3400 GOTTINGEN,GERMANY
[2] ROTTA RES LAB SPA,I-20052 S FRUTTUOSO MONZA,ITALY
来源
AMERICAN JOURNAL OF PHYSIOLOGY | 1991年 / 260卷 / 02期
关键词
CHOLECYSTOKININ RECEPTOR ANTAGONIST; GALLBLADDER CONTRACTION; PANCREATIC SECRETION; STEATORRHEA; TRANSIT TIME;
D O I
10.1152/ajpgi.1991.260.2.G197
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
To evaluate the physiological role of cholecystokinin (CCK) in humans, we studied the influence of the specific CCK receptor antagonist loxiglumide (CR 1505) on gallbladder contraction, pancreatic enzyme output, plasma CCK concentrations, mouth-to-cecum transit time (MCTT), stool weight, and fecal fat excretion. Infusion of CCK-8, producing CCK plasma levels of 10-12 pmol/l, decreased gallbladder volume to 21% of the initial volume (P < 0.01) and increased bilirubin output 8- to 10-fold and pancreatic enzyme secretion 2- to 4-fold. Infusion of loxiglumide (10 mg.kg-1.h-1 iv) abolished CCK-8-stimulated enzyme and bilirubin output. Basal gallbladder volume increased 68% during loxiglumide infusion (P < 0.001) and 137% (P < 0.001) after 7 days of oral loxiglumide treatment (3 x 1.6 g/day). Gallbladder contraction and bilirubin output in response to the intraduodenal instillation of a liquid meal (382 kcal) was completely inhibited by loxiglumide; gallbladder volume even increased 45% postprandially during loxiglumide infusion (P < 0.02) and 145% after long-term loxiglumide treatment (P < 0.001). Meal-stimulated pancreatic enzyme output was diminished 46-53% after acute and 25-29% after chronic administration of loxiglumide. Meal-stimulated integrated plasma CCK-immunoreactive (CCK-ir) concentrations, determined by RIA, were 3.2-fold higher during loxiglumide infusion (P < 0.02); plateau CCK levels were markedly elevated (10.1 +/- 1.4 vs. 3.7 +/- 0.5 pM). Plasma CCK-like bioactivity, measured by a sensitive bioassay, was identical to CCK-ir levels in the absence of loxiglumide; in the presence of loxiglumide, no circulating CCK-like bioactivity was detectable, indicating complete inhibition of plasma CCK. MCTT was augmented 24% (P < 0.05). Oral treatment with loxiglumide increased stool weight 72% P < 0.01) and fecal fat excretion 186% (P < 0.001). In conclusion, 1) meal-induced gallbladder contraction and fasting tone are primarily controlled by CCK; 2) the contribution of CCK to the intestinal phase of postprandial pancreatic enzyme secretion is 40-50%; 3) GI motility and absorption are partially controlled by CCK; and 4) postprandial CCK secretion is substantially augmented by loxiglumide via an unknown mechanism.
引用
收藏
页码:G197 / G206
页数:10
相关论文
共 47 条
  • [31] MAKOVEC F, 1985, ARZNEIMITTELFORSCH, V35-2, P1048
  • [32] MALAWER SJ, 1967, GASTROENTEROLOGY, V53, P250
  • [33] ROLE OF CHOLECYSTOKININ IN REGULATION OF GASTROINTESTINAL MOTOR FUNCTIONS
    MEYER, BM
    WERTH, BA
    BEGLINGER, C
    HILDEBRAND, P
    JANSEN, JBMJ
    ZACH, D
    ROVATI, LC
    STADLER, GA
    [J]. LANCET, 1989, 2 (8653) : 12 - 15
  • [34] UBER DIE BESTIMMUNG VON TRYPSIN UND CHYMOTRYPSIN MIT AMINOSAURE-P-NITROANILIDEN
    NAGEL, W
    WILLIG, F
    PESCHKE, W
    SCHMIDT, FH
    [J]. HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1965, 340 (1-2): : 1 - &
  • [35] EFFECTS OF LOXIGLUMIDE ON GALLBLADDER EMPTYING IN HEALTHY-VOLUNTEERS
    NIEDERAU, C
    HEINTGES, T
    ROVATI, L
    STROHMEYER, G
    [J]. GASTROENTEROLOGY, 1989, 97 (05) : 1331 - 1336
  • [36] FEEDBACK-REGULATION OF PANCREATIC-ENZYME SECRETION - SUPPRESSION OF CHOLECYSTOKININ RELEASE BY TRYPSIN
    OWYANG, C
    LOUIE, DS
    TATUM, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) : 2042 - 2047
  • [37] PENDLETON RG, 1987, J PHARMACOL EXP THER, V241, P110
  • [38] RICK W, 1969, Z KLIN CHEM KLIN BIO, V7, P530
  • [39] RICK W, 1970, METHODEN ENZYMATISCH, V1, P848
  • [40] VAGAL INFLUENCE ON CHOLECYSTOKININ AND NEUROTENSIN RELEASE IN CONSCIOUS DOGS
    SCHAFMAYER, A
    NUSTEDE, R
    POMPINO, A
    KOHLER, H
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1988, 23 (03) : 315 - 320